GleamWall
中文EN

DCTH DELCATH SYSTEMS, INC.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 872912 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY38.1%
TTM net income YoY455.4%
TTM EPS YoY433.3%
Revenue 3-yr CAGR270.3%
Net income 3-yr CAGR—

Margins

Gross margin87.6%
Operating margin5.2%
Net margin6.1%
FCF margin18.3%
EBITDA margin5.6%

Returns

ROE5.4%
ROA4.9%
ROIC (approx.)5.6%
Asset turnover0.80x

Leverage & solvency

Liabilities / assets10.4%
Debt / equity0.00x
Current ratio10.87x
Interest coverage—

Cash quality & payout

Operating cash flow / net income3.46x
Accruals ratio-12.0%
Payout ratio—
Capex / revenue2.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$35.10M$29.13M$24.99M$20.73M$20.56M$24.16M$19.78M$15.10M
Cost of revenue$3.92M$2.98M$3.74M$3.01M$2.62M$3.32M$2.85M$2.13M
Gross profit$31.18M$26.15M$21.26M$17.72M$17.94M$20.84M$16.94M$12.97M
R&D expense$11.01M$10.38M$9.82M$9.37M$7.99M$6.88M$5.01M$2.91M
SG&A expense$13.06M$13.37M$13.07M$10.53M$10.34M$11.37M$11.29M$7.02M
Operating income$7.12M$2.40M-$1.64M-$2.18M-$388,000$2.59M$642,000$3.04M
Pretax income$7.97M$3.16M-$908,000-$1.33M$375,000$3.21M$1.26M-$3.40M
Income tax$1.01M$491,000$162,000$562,000-$455,000$508,000$195,000$0
Net income$6.95M$2.67M-$1.07M-$1.90M$830,000$2.70M$1.07M-$3.40M
EBITDA$7.32M$2.50M-$1.53M-$2.10M-$288,000$2.69M$685,000$3.08M
EPS (basic)0.190.07-0.03—0.020.080.03—
EPS (diluted)0.170.07-0.03—0.020.070.03—
Weighted avg. shares (diluted)41.02M39.76M36.02M—40.06M40.26M39.51M—
Balance sheet
Cash & equivalents$55.54M$47.52M$41.31M$43.45M$41.81M$34.42M$12.78M$32.41M
Short-term investments$48.78M$48.38M$47.99M$47.58M$47.10M$46.58M$46.12M$20.82M
Receivables$20.21M$15.94M$14.16M$11.74M$13.75M$15.84M$13.94M$10.89M
Inventory$10.50M$11.71M$9.81M$10.25M$10.74M$10.52M$7.13M$6.93M
Current assets$141.56M$130.54M$120.27M$119.53M$120.61M$113.48M$84.35M$73.76M
PP&E, net$5.13M$4.02M$3.66M$3.17M$2.71M$2.40M$1.95M$1.79M
Total assets$149.09M$137.02M$124.84M$123.63M$124.30M$116.88M$87.32M$76.59M
Current liabilities$13.02M$13.28M$10.70M$10.95M$8.01M$10.44M$5.29M$6.14M
Long-term debt———————$0
Total debt———————$0
Total liabilities$15.55M$15.87M$12.13M$12.41M$9.45M$11.89M$7.09M$7.84M
Shareholders' equity$133.54M$121.14M$112.71M$111.22M$114.85M$104.99M$80.23M$68.75M
Net debt———————-$32.41M
Shares outstanding34.77M34.64M34.47M34.69M35.31M34.96M33.44M33.06M
Cash flow statement
Operating cash flow$8.18M$5.71M$857,000$8.25M$4.77M$7.29M$2.20M-$1.01M
Capital expenditure$1.26M$503,000$570,000$550,000$459,000$398,000$140,000$229,000
Free cash flow$6.92M$5.21M$287,000$7.70M$4.31M$6.89M$2.06M-$1.24M
Investing cash flow-$1.26M-$504,000-$571,000-$561,000-$466,000-$415,000-$25.15M-$15.23M
Financing cash flow$1.10M$962,000-$2.38M-$5.94M$3.10M$14.64M$3.25M$40.38M
Depreciation & amortization$200,000$100,000$102,000$80,000$100,000$100,000$43,000$38,000
Stock-based compensation$4.23M$5.12M$4.95M$4.51M$5.65M$7.21M$6.86M$1.61M
Share buybacks$0$11,000$3.00M$6.00M$0$0$0—

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.